The circadian nature of mood and its dysfunction in affective disorders is well recognized, but the underlying molecular mechanisms are still unclear. Here, we show that the circadian nuclear receptor REVERBa, which is associated with bipolar disorder, impacts midbrain dopamine production and moodrelated behavior in mice. Genetic deletion of the Rev-erba gene or pharmacological inhibition of REV-ERBa activity in the ventral midbrain induced mania-like behavior in association with a central hyperdopaminergic state. Also, REV-ERBa repressed tyrosine hydroxylase (TH) gene transcription via competition with nuclear receptor-related 1 protein (NURR1), another nuclear receptor crucial for dopaminergic neuronal function, thereby driving circadian TH expression through a target-dependent antagonistic mechanism. In conclusion, we identified a molecular connection between the circadian timing system and mood regulation, suggesting that REVERBa could be targeting in the treatment of circadian rhythm-related affective disorders.
INTRODUCTION
Most physiological and behavioral functions in mammals are constrained by daily oscillations generated by an internal timekeeping system composed of clock proteins with interacting positive and negative feedback loops. This hierarchically organized circadian timing system, with a master clock in the hypothalamic suprachiasmatic nucleus (SCN) and subsidiary clocks in extra-SCN brain regions and peripheral organs, mediates periodicities in physiological and behavioral output by regulating cell type-specific sets of clock-controlled genes (Takahashi et al., 2008; Menet and Rosbash, 2011) .
Disrupted circadian rhythm is a key feature of affective disorders, including major depressive disorder (MDD), bipolar disorder (BPD), and seasonal affective disorder, which frequently involve dysfunctions of midbrain dopaminergic (DAergic) neurons underlying the brain reward system (Wulff et al., 2010) . Recent animal studies show that defective expression of clock genes leads to behavioral abnormalities similar to those observed in human mood disorders. For example, mice with a defective allele of the circadian locomotor output cycles kaput (Clock) gene (ClockD19) display mania-like behavior, robust cocaine sensitization, and increased midbrain DAergic activity (McClung et al., 2005; Roybal et al., 2007) . The knockdown of Clock mRNA expression in the ventral tegmental area (VTA) leads to a BPD-like phenotype characterized by a reduction in anxietylike behavior but increased depression-like behavior (Mukherjee et al., 2010) . Mutations of other clock genes also produce behavioral abnormalities. For example, mice deficient in brain and muscle or Period 2 (Per2) genes exhibit mania-like behavior, whereas mice lacking both Cryptochrome 1 and 2 genes show altered anxiety-like behavior (Hampp et al., 2008; Kondratova et al., 2010; De Bundel et al., 2013) . These findings suggest that molecular components of the circadian timing system have critical roles in mood regulation.
Accumulating clinical evidence implies the involvement of the circadian nuclear receptor REV-ERBa in mood regulation. REVERBa, which is encoded by the NR1D1 gene, constitutes a stabilizing feedback loop by repressing the transcription of Bmal1 mRNA, which encodes a core transcriptional activator of circadian molecules (Preitner et al., 2002) . Genetic variations in human NR1D1 loci are associated with BPD onset and responsiveness to lithium (Kripke et al., 2009; Severino et al., 2009; Etain et al., 2011) . In this regard, it is noteworthy that lithium-sensitive glycogen synthase kinase 3 (GSK3) phosphorylates and stabilizes REV-ERBa, influencing its ability to repress the transcription of downstream targets (Yin et al., 2006) . Furthermore, certain alleles in NR1D1 and GSK3b loci have additive effects on lithium responsiveness among BPD patients (McCarthy et al., 2011) . Therefore, the present study aims to elucidate whether REVERBa impacts mood by linking the molecular circadian clock with the mood-controlling central DAergic system.
RESULTS

Abnormal Mood-Related Phenotypes of REVERBa-Deficient Mice
To explore whether REV-ERBa plays a role in mood regulation, we characterized the emotional phenotypes of Rev-erba knockout (RKO) mice. In the despair-based tail suspension test (TST) and forced swim test (FST), wild-type (WT) mice exhibited daily variation in depression-like behaviors ( Figure 1A ) with greater durations of immobility at subjective dusk (circadian time [8] [9] [10] [11] [12] ) than at subjective dawn (CT22-02). By contrast, RKO mice exhibited no such variation in behavior and less depression-like behavior at dusk. Anxiety phenotypes also differed between RKO and WT mice. WT mice showed more anxiety-like behavior in the elevated plus-maze (EPM) at dusk, whereas RKO mice spent similar times in open arms at dusk and dawn ( Figure 1B ). WT mice also showed faster locomotor habituation to a novel environment ( Figure 1C , left) and traveled less distance at dusk than at dawn ( Figure 1C, right) , whereas RKO mice did not exhibit time-of-day variation in locomotion. Furthermore, male RKO mice were more aggressive than WT mice. Less than 20% of WT mice attacked a castrated male intruder, whereas more than 50% of RKO mice frequently attacked an intruder ( Figure 1D ). Daily variation in aggression was not found for either WT or RKO mice. It is noteworthy that reduced depression-like behavior, increased risk-taking and hyperactivity, and unusual aggression are considered mania-like phenotypes in rodents (Cryan and Slattery, 2007) . On the other hand, innate fear response was more robust in RKO mice than in WT mice, as RKO mice froze more upon exposure to synthetic predator feces odor (trimethylthiazoline [TMT]; Figure 1E ) at dusk. These findings suggest that RKO mice exhibit emotional instability, mimicking, at least in part, symptoms observed in human BPD patients.
Tyrosine Hydroxylase Mediates Circadian Nature of Mood-Related Behavior Abnormal mood-related behaviors, particularly mania-like phenotypes, often involve midbrain DAergic system dysfunction (Nieoullon, 2002; Wulff et al., 2010) . Considering the transcriptionally repressive activity of REV-ERBa, we examined genome-wide gene expression profiles in ventral midbrain (VMB) tissue, where DAergic neurons are enriched. Microarray analysis identified a subset of differentially expressed mRNAs between RKO and WT mice ( Figure S1A ). Notably, expression levels of tyrosine hydroxylase (TH) mRNA, which encodes a rate-limiting enzyme for DA biosynthesis, was higher in RKO than in WT mice. Its time-of-day expression pattern in WT mice was comparable to that of Bmal1 mRNA, which is the primary target of REV-ERBa (Figure 2A, top) . TH and Bmal1 mRNA levels were elevated at night, which differed from the circadian oscillations of Rev-erba and Per2 mRNA levels (Figure 2A, bottom) . Expression levels of Nurr1 mRNA, a key transcriptional activator of TH, other DA-related genes (Zetterströ m et al., 1997) , and other mRNA species related to DAergic functions, were less affected by time of day or the loss of functional REV-ERBa (Figures S1B and S1C) . Immunohistochemistry revealed that TH protein expression exhibited similar circadian variations in the substantia nigra (SN) and VTA of WT mice ( Figure 2B ). Quantitative analysis based on fluorescence-activated cell sorting (FACS) supported this finding, showing that the proportion of TH-immunoreactive cells relative to NeuN-positive neuronal populations was higher at CT00 than at CT12 (Figures 2C and S2 ). Such daily variations were absent in RKO mice due to abnormally high TH expression in both the SN and VTA at dusk ( Figure 2D ). These results suggest that REV-ERBa regulates TH expression by a suppressive mechanism. To test whether altered TH expression leads to changes in mood-related behavior, we constitutively expressed C-terminally Myc-tagged human TH (hTH-Myc) under the control of a CMV promoter in the VTA via an adeno-associated viral (AAV) vector system. Immunostaining of AAV-infected mouse brain sections with anti-TH or anti-Myc tag antibody showed that approximately one-third of TH-positive cells in the VTA coexpressed Myc-tagged TH ( Figure 2E ; 41.11% ± 5.14%, n = 6, calculated from three to four randomly chosen sections per mouse within ±0.5 mm of the injection site). As expected, transfected cells were mainly found in the VTA and rarely in the SN. We then carried out behavioral testing of hTH-Myc-expressing and GFP-transfected control mice at CT08-12. Similar to RKO mice, Myc-tagged hTH-expressing mice showed reduced despair-( Figure 2F ) and anxiety-like behavior ( Figure 2G ) and more robust innate fear ( Figure 2H ). However, novelty-induced locomotion was equivalent in hTH-expressing and control mice ( Figure 2I ), presumably because TH-immunoreactive neurons were predominantly colocalized with viral-expressed hTH in the VTA rather than the SN, where DAergic neurons are more heavily involved in motor function (Nieoullon, 2002) . These findings indicate that arrhythmic and increased TH expression has a role in the mania-like phenotype of RKO mice.
Midbrain DAergic Activity in REV-ERBa-Deficient Mice Next, we compared central DAergic activity between RKO and WT mice. We examined spontaneous DA release from striatal tissue, containing both the caudate putamen (CPu) and nucleus accumbens (NAc) , that was statically incubated ex vivo. WT striatal cultures prepared at CT00 released more DA than those at CT12, but this variation was absent in RKO tissue due to elevated DA release at CT12 ( Figure 3A ). Along with similar profiles of striatal DA contents and increased metabolite levels (Figures S3A and S3B) , these results indicate that RKO mice show altered DA production. Also, in vivo microdialysis revealed that extracellular levels of DA and its metabolites were augmented in the NAc of freely moving RKO compared with WT mice (Figures 3B, S3C, and S3D) . Consistent with increased extracellular DA levels, REV-ERBa also had a profound influence on VMB electrophysiological properties ( Figures 3C and S4 ). Multi-electrode array recordings of single units in the VTA revealed that acute inhibition of REV-ERBa activity by intracerebroventricular (i.c.v.) application of the potent REV-ERBa antagonist SR8278 (Kojetin et al., 2011) augmented overall firing rate in freely moving mice compared with vehicle injection regardless of the time of day ( Figure 3C ), likely due to an increased proportion of fastspiking neurons ( Figure S4 ). This increase in DA biosynthesis and secretion in the VMB indicates a hyperDAergic state in RKO mice.
We next examined whether increased DAergic activity was associated with altered mood-related behavior in RKO mice. Systemic administration of the DA receptor antagonist haloperidol (HALO) or the TH inhibitor a-methyl-p-tyrosine (AMPT) attenuated daily variations in mood-related behavior in WT mice by increasing depression-and anxiety-like behavior, particularly during late nighttime (CT20-24). More importantly, behavioral abnormalities of the RKO mice observed at dusk were ameliorated to levels comparable to those observed in WT mice after application of either inhibitor (Figures 3D and 3E) . Both inhibitors also reduced locomotion in WT mice at night and hyperactivity in RKO mice during the day (Figures S5A and S5B) and completely inhibited aggression in WT and RKO mice (data not shown). We cannot completely rule out the possibility that altered motor activity influenced the behavioral responses because these inhibitors increased freezing behaviors of WT mice tested at dusk ( Figure S5C ). Taken together with hTHMyc expression ( Figures 2E-2I ), our findings suggest that certain mechanism(s) responsible for hyperDAergic activity during rest periods may underlie reduced depression-and anxiety-like behavior in RKO mice.
Inhibition of REV-ERBa Activity in the VMB Produces Mania-like Behavior As most TH-immunoreactive DA neurons coexpressed canonical clock proteins such as REV-ERBa, BMAL1, and PER1 (Figure 4A) , we asked whether REV-ERBa locally expressed in the VMB controls TH expression and impacts mood regulation. Local inhibition of REV-ERBa activity by microinfusion of SR8278 into the VMB of WT mice increased TH and Bmal1 mRNA expression at CT12 to levels comparable to those in RKO mice, but SR8278 failed to alter TH expression in RKO mice ( Figure 4B ), raising the possibility that REV-ERBa in the VMB directly modulates TH mRNA expression.
Microinfusion of SR8278 into the VMB but not a control region (i.e., periventricular gray [PVG] ) resulted in behavioral abnormalities comparable to those found in RKO mice. SR8278 decreased despair-like immobility in WT mice during the day (CT08-12 or zeitgeber time [8] [9] [10] [11] [12] ) to a level comparable to that in RKO mice, whereas it barely affected despair-like behavior during the active period (CT or ZT20-24, Figure 4C ). Also, SR8278-infused mice showed less anxiety-like behavior at dusk ( Figures 4D and S6 ), more innate fear ( Figure 4E ), and more aggression ( Figure 4F ) than vehicle-injected or PVG-targeted mice.
When exposed to novelty, SR8278-infused WT mice were more hyperactive than RKO mice under constant darkness, traveling two to three times longer distances than WT mice at CT20-24 ( Figure 4G ), whereas total distance traveled was equivalent between RKO and WT mice at dawn ( Figure 1C ). In this regard, it is noteworthy that RKO mice show impaired exercise capacity due to reduced mitochondrial content and oxidative functions of skeletal muscle (Woldt et al., 2013) . Because microinfusion of SR8278 into the VMB did not disrupt the muscular action of REV-ERBa, it is therefore plausible that a more robust locomotor response could be observed. SR8278-infused mice also showed hyperactivity in response to novelty during the dark period of the LD cycle, but mice were less active during the light period even though testing occurred under dim red lighting. Considering that SR8278-infused mice traveled longer distances than control mice at ZT08-12 under the same lighting conditions, it appears that exposure to light prior to testing may temporarily inhibit locomotor activity. Taken together, these results demonstrate that REV-ERBa activity in the VMB plays a central role in controlling mood and TH mRNA expression. Antagonistic Crosstalk between REV-ERBa and NURR1 in the Regulation of TH Gene Transcription Because local REV-ERBa activity in the VMB controls TH mRNA expression, we tested whether REV-ERBa directly regulates TH gene transcription by acting on its promoter using an immortalized DAergic cell line (CATH.a; Suri et al., 1993) . Sequence analysis suggests several putative REV-ERBs/retinoic acid receptor-related orphan nuclear receptor (ROR) response elements (RREs), as well as E-box elements, which are recognized by the CLOCK:BMAL1 heterodimer in the rat TH promoter region located within $5 Kb upstream of the coding sequence. Some of these are well conserved among rats, mice, and humans (Figure 5A ). REV-ERBa repressed rat TH promoter-driven luciferase reporter (rTH-LUC) activity, but RORa and the CLOCK:BMAL1 heterodimer had little effect ( Figure 5B ). Interestingly, putative RREs in the TH promoter overlapped with previously identified cis-elements recognized by the nuclear receptor NURR1 (NBRE: NGFI-B response element; Figure 5A ), which is required for proper development and function of DAergic neurons (Zetterströ m et al., 1997; Kim et al., 2003) . REV-ERBa antagonized NURR1-induced activation of the TH promoter, whereas the Bmal1 promoter was barely affected by NURR1 overexpression ( Figure 5B ). Such antagonistic crosstalk between REV-ERBa and NURR1 was also demonstrated for mouse and human TH promoter-driven reporters (mTH-LUC and hTH-LUC, respectively), indicating evolutionary conservation ( Figure 5C ).
Serially truncated TH promoters and the 2.4 Kb promoters with site-specific deletions revealed that two putative RREs/NBREs (designated as R/N1 and R/N2, respectively) in a region between 2.6 and 1.2 Kb of the TH promoter serve as the main cis-acting sites of this crosstalk ( Figures 6A, 6B , and S7). Modulation of endogenous REV-ERBa activity by treatment with REV-ERBa agonist GSK4112 (Meng et al., 2008) or antagonist SR8278 differentially influenced TH promoter activity in an R/N1-and R/N2-dependent manner ( Figure 6C ). Consistently, chromatin immunoprecipitation (ChIP) assays revealed that both REVERBa and NURR1 directly bound to R/N1 and R/N2 but did not recognize the proximal NBRE on the TH promoter or the RRE element on the Bmal1 promoter, respectively ( Figure 6D ). This led us to ask how these nuclear receptors cooperate at their recognition sites on the TH promoter. We found that an increasing amount of GFP-tagged REV-ERBa repressed FLAG-conjugated NURR1-induced TH promoter activation in a dose-dependent manner ( Figure 6E ). Accordingly, expression of GFP-REV-ERBa and Flag-NURR1 at different molar ratios followed by quantitative ChIP assays demonstrated that these nuclear receptors compete to recognize R/N1 and R/N2 elements ( Figure 6F ). We thus speculate that target-dependent antagonistic crosstalk between the two nuclear receptors underlies circadian TH expression.
REV-ERBa-Dependent Regulation of Histone Acetylation at the TH Promoter
We next examined whether REV-ERBa and NURR1 also competitively bind to R/N1 and R/N2 elements in vivo. Binding of REV-ERBa to both R/N1 and R/N2 elements in WT VMB lysates was stronger at CT12 than at CT00, with the opposite pattern observed for NURR1 ( Figure 7A ). Daily variation in REV-ERBa binding appeared to be more robust in the proximal R/N1 element, whereas NURR1 more efficiently bound to the R/N2 site. At CT12, the binding of NURR1 to the R/N elements was higher for RKO than for WT mice ( Figure 7A ), and NURR1-R/N1 binding was moderately higher in RKO mice at CT12 than in WT mice at CT00. These findings indicate that target-dependent antagonistic crosstalk between these nuclear receptors can occur through competitive binding to R/N elements in vivo.
REV-ERBa represses target gene transcription by recruiting histone deacetylase 3 (HDAC3) complexes to the promoter region (Yin and Lazar, 2005; Feng et al., 2011) . Thus, we examined HDAC3 recruitment to the TH promoter region and its subsequent histone acetylation state. HDAC3 recruitment to the R/ N1 site followed a circadian rhythm in the WT VMB, but this rhythm was absent in the RKO VMB ( Figure 7B ). By contrast, there was little daily variation in HDAC3 recruitment to the more distal R/N2 site, suggesting that it is less efficiently occupied by REV-ERBa than the R/N1 site in vivo, as also implicated in Figure 7A . Acetylation at lysine 9 of histone H3 (H3-K9) showed a circadian rhythm at all three examined TH promoter regions in a REV-ERBa-dependent manner ( Figure 7C ). The circadian pattern of histone acetylation coincides well with the TH mRNA expression profile but is opposite to those for occupations by REV-ERBa or HDAC3. H3-K9 acetylation and HDAC3 recruitment to the proximal promoter region (PROX) resulted in daily oscillations comparable to those found in the R/N1-containing region. Taken together, these results suggest that REV-ERBa controls TH gene expression by recruiting HDAC3 complexes, which negatively regulate permissive histone acetylation to suppress transcriptional activation of the TH gene promoter.
DISCUSSION
The present study addresses the long-standing issue of the circadian nature of mood regulation, which is thought to be dysfunctional in a variety of mood disorders. We demonstrated that the circadian nuclear receptor REV-ERBa particularly expressed in the VMB plays a pivotal role in controlling DAergic function and mood-related behavior, as genetic ablation or pharmacological inhibition of REV-ERBa affected mood in mice. Unlike canonical RRE-mediated cyclic gene expression regulated by competitive actions of REV-ERBs and RORs, REV-ERBa competed with NURR1, a DA neuron-enriched nuclear receptor, to regulate cyclic TH gene transcription, thereby contributing to the circadian rhythmicity of the DAergic system ( Figure 7D ).
Patients with affective disorders such as BPD and MDD commonly suffer from disrupted sleep-wake cycles and dysregulated diurnal mood variation (Wulff et al., 2010; McCarthy and Welsh, 2012) . Recent advances in chronobiological research facilitate the functional dissection of molecular links between circadian timing and mood-controlling systems. Several previous studies of mutant mice with defective circadian clock genes suggest crosstalk between molecular components of the circadian clock and DAergic signaling at various regulatory steps such as DA biosynthesis, transmission, and turnover (McClung et al., 2005; Hampp et al., 2008; Spencer et al., 2012) . As a result, several key DA-regulating genes are proposed to be controlled by circadian clockwork. For example, TH mRNA expression is augmented in the VMB of ClockD19 mutant mice, suggesting that TH is negatively regulated by CLOCK (McClung et al., 2005) . Rather than direct control by CLOCK:BMAL1 heterodimer, the present study along with a previous report (Lemos et al., 2007) suggests an indirect mechanism, although a noncanonical mechanism cannot be ruled out. DAergic neural activity and associated TH expression are also involved in the manialike phenotype of ClockD19 mice (McClung et al., 2005; Aumann et al., 2011). Considering that Rev-erba mRNA expression is severely attenuated in ClockD19 mice (Triqueneaux et al., 2004) , REV-ERBa may mediate the circadian control of DA biosynthesis through transcriptional regulation of TH gene expression.
Despite emerging evidence of a link between molecular pathways controlling circadian rhythms and DAergic transmission, important issues still remain. For instance, circadian rhythm amplitude, rather than steady-state activity, is likely more important for proper mood regulation. Recent observations that mood stabilizers such as lithium and valproic acid increase the amplitude of clock gene expression rhythms support this hypothesis (Johansson et al., 2011; Li et al., 2012) . Furthermore, fibroblasts obtained from BPD patients tend to exhibit lower amplitudes of clock gene expression rhythms (Yang et al., 2009) . Another important issue concerns additional neural substrates related to the circadian nature of mood control. Despite our demonstration that REV-ERBa actions in the DAergic system profoundly influence mood-related behaviors in mice, clinical studies suggest the involvement of multiple neural circuits, such as the limbic system and underlying molecular mediators, in human affective disorders (Wulff et al., 2010; McCarthy and Welsh, 2012) . Therefore, molecular nodes linking the circadian timing and mood-controlling systems in discrete brain regions should be systematically evaluated in consideration of their dynamic and networking properties.
Genetic ablation or acute inhibition of REV-ERBa as well as ectopic TH expression increased innate fear of predator odor at dusk, whereas they usually led to attenuated depressive/ anxious state and induced a hyperlocomotive response to novelty. Interestingly, controversial findings based on optogenetic manipulation of DAergic neural activity were recently reported; (Tye et al. 2013 ) demonstrated that phasic activation of DA neurons in the VTA relieves a depression-like phenotype evoked by chronic stress. Conversely, Chaudhury et al. (2013) reported that similar activation of DA neurons during a social-interaction test promotes a depression-like phenotype in a VTA-NAc circuitdependent manner. These findings support the idea that a stress-responsive system may be involved in circadian dysregulation in affective disorders (McClung, 2013) . Given that impaired REV-ERBa activity in the VMB led to increased DAergic activity by inducing DA production and neural hyperactivity, it is reasonable to speculate that emotional instability may depend on discrete target regions/circuits of the central DA system in combination with differential contexts, such as the mode and extent of stressful stimuli.
REV-ERBa and its ortholog REV-ERBb are believed to compete with RORs in controlling RRE-mediated transcription (Preitner et al., 2002) . We demonstrated that REV-ERBa can also antagonize NURR1-induced TH gene transcription by modulating permissive histone modification in a target promoter-dependent manner. Despite the presence of specialized cis-element(s) for crosstalk, the proximal NBRE element(s), to which NURR1 but not REV-ERBa can bind, may still play a functional role in the transcriptional regulation of the TH gene. These characteristics provide a plausible explanation for why elimination of R/N elements barely increased basal TH promoter activity, unlike Bmal1 expression (Preitner et al., 2002; Ueda et al., 2002) . In contrast to the ubiquitously expressed REV-ERBa, NURR1 is enriched in the central nervous system, especially in the basal ganglia and limbic areas (Zetterströ m et al., 1997) . Therefore, direct competition between these nuclear receptors on specific cis-elements in the distal TH promoter exemplifies a novel tissue-specific type of regulation. In this regard, it should be noted that PER2 coordinates various nuclear receptors, including REV-ERBa, via protein-protein interactions, suggesting possible (B) Transcriptional activities of 2.4 Kb WT and mutated (m1, m2, and m1/2) TH promoters by NURR1 and/or REV-ERBa expression (n = 3-6). Luciferase activities were normalized by cotransfected pRL-TK; mean values of WT promoter activities in empty vector-transfected cells were set to 1. (C) Effect of GSK4112 or SR8278 on TH promoter activity (**p < 0.01 versus other treatment; n = 7-16). Data was presented as mean ± SEM. (D) ChIP assays on GFP-REV-ERBa and FLAG-NURR1-expressing CATH.a cell lysates. Immunoprecipitation was performed using anti-GFP (REV), anti-Flag (NUR), or anti-Histone H3 (H3) antibody. Pre-immune IgG was used as a negative control. Indicated cis-element-containing fragments were amplified by PCR (NBRE: proximal NBREs in the TH promoter; RRE: proximal RRE in the Bmal1 promoters). (E) Dose-dependent repressive effect of REV-ERBa on TH promoter activity. The REV-ERBa expression construct was transfected with empty or NURR1-expressing plasmid at the indicated ratios (n = 4). (F) ChIP assays followed by qPCR on CATH.a cell lysates transfected with GFP-REV-ERBa-and/or FLAG-NURR1-expressing constructs at the indicated ratios. Relative binding was calculated as mean ± SEM % of maximal binding obtained from lysates expressing only one construct (n = 3). See also Figure S7 . crosstalk between REV-ERBa and other nuclear receptors (Schmutz et al., 2010) . A recent attempt to identify genomewide cis-acting REV-ERBs targets in liver tissue showed that a broad range of nuclear receptor-binding sites are recognized by REV-ERBa in addition to its classical binding motif (Cho et al., 2012) . REV-ERBa may likely be a more versatile regulator of nuclear receptor signaling and mediator of functional circadian outputs than previously thought, particularly with regard to its actions in cellular context-and target-dependent manners.
Because heme was identified as an endogenous ligand for REV-ERBs (Raghuram et al., 2007; Yin et al., 2007) , they have been considered the most promising target of small molecules to treat circadian rhythm-related metabolic, cardiovascular, and psychiatric disorders. Several synthetic REV-ERBa/b modulators have been evaluated to test this idea (Meng et al., 2008; Kojetin et al., 2011; Solt et al., 2012) . (Solt et al. 2012) recently developed potent REV-ERBa/b agonists allowing in vivo application. Peripheral REV-ERBs are believed to have important roles in glucose and lipid metabolism, as revealed by expression profiles of metabolic genes in the liver, skeletal muscle, and adipose tissue (Le Martelot et al., 2009; Cho et al., 2012; Solt et al., 2012) . Based on these roles, researchers examined the effects of REV-ERBs agonists in diet-induced obese mice and proposed that REV-ERBs ligands have clinical applications for the treatment of metabolic diseases and sleep disorders (Solt et al., 2012) .
In conclusion, the present study demonstrates that midbrain REV-ERBa links the molecular circadian clock with DA biosynthesis and thereby impacts mood regulation. Our findings suggest the potential of REV-ERBa as a therapeutic target for affective disorders associated with circadian dysfunction.
EXPERIMENTAL PROCEDURES Animals
Male RKO and WT mice (10-15 weeks of age) were maintained in a C57BL/6J background. Mice were housed in temperature-controlled (22 C-23 C) quarters under a 12 hr light-dark (LD) photoperiod (lights on at 8:00 a.m.). After entrainment for >10 days under LD conditions, mice were kept in constant darkness (DD) for 2 days starting at lights-off time. On the third day, mice were sacrificed at indicated time points by cervical dislocation. All behavioral tests under DD conditions were performed on the third or fourth day. All procedures were approved by the Institutional Animal Care and Use Committee of Seoul National University.
Plasmids Expression vectors were previously described (Chopin-Delannoy et al., 2003; Kim et al., 2003; Son et al., 2008) . The rat 5.2 Kb TH promoter and its seriallydeleted derivatives were also previously described (Kim et al., 2003) . WT and site-specifically mutated 2.4 Kb rat (À2,451 to À9 from translation start site), mouse (À2,306 to À1), and human TH promoters (À2,523 to +76) were prepared by PCR as described in the Extended Experimental Procedures.
Drug Application HALO (0.2 mg/kg; Sigma-Aldrich) or AMPT (100 mg/kg; Sigma-Aldrich) were injected intraperitoneally (i.p.) 1-2 hr before the test. SR8278 was administered i.c.v. (64 mg/mouse) 6 hr before electrophysiological recordings. For behavioral studies and gene expression analyses, SR8278 was directly microinfused into the VMB (16 mg/mouse) or PVG 4 hr before experiments. Detailed procedures are described in the Extended Experimental Procedures.
Behavioral Studies
All behavioral tests were carried out at the indicated time of day under dim red light.
Depression-like Behavior
Despair-based TST and FST were performed as previously described (Roybal et al., 2007; Hampp et al., 2008) with modifications. For the TST, mice were individually suspended by the tail in a white box (36.5 3 30.5 3 30.5 cm) for 6 min. They were considered immobile when agitation and escape attempts ceased. For the FST, mice were placed in a transparent beaker (10 cm diameter) containing water (21 C-25 C) at a depth of 15 cm for 6 min. Immobility, defined as the absence of volitional body or limb movement, was scored as the percentage of time spent immobile during the last 4 min. EPM EPM testing was performed as previously described (Chung et al., 2005) . 
Novelty-Induced Locomotion
The locomotor habituation test was conducted as previously described (Son et al., 2007) with modifications. Mice were individually placed into a novel Plexiglas box (217 3 268 3 104 mm) with bedding for 2 hr. Behavior was recorded by an overhead video camera connected to a computer with tracking software (Ethovision 3.1, Noldus).
Innate Fear in Response to Predator Odor
Mice were placed in a chamber with a beaker containing 30 ml TMT (PheroTech) as previously described (Lee et al., 2011) . Freezing behavior was measured for 10 min and scored as the percentage of time spent freezing during the last 4 min. Aggression Aggression was measured as previously described (Chamero et al., 2007) with modifications. Male mice were isolated for 1 week before testing, and a castrated male BALB/c intruder (8-9 weeks of age) was placed in their home cage for 5 min. Numbers of aggressive contact behaviors such as tail rattling, biting, chasing, and cornering were counted.
RNA and Protein Analyses
Tissue was rapidly removed and frozen in liquid nitrogen. Total RNA was isolated by the single-step acid guanidinium thiocyanate-phenol-chloroform method. Samples for immunoblot analyses were prepared by homogenization of tissue in SDS lysis buffer. Detailed protocols for RNA and protein analyses are described in the Extended Experimental Procedures.
FACS Analysis
Flow cytometry for DAergic neuronal populations was performed as previously described (Guez-Barber et al., 2012) . VMB tissue was rapidly dissected on an ice-chilled brain-matrix from 2 mm thick brain sections (two mice per analysis), minced in ice-cold Hybernate A solution (Invitrogen), dissociated by incubation with Accutase (Millipore), and subjected to FACS analyses as described in the Extended Experimental Procedures.
DA Measurement
Ex vivo superfusion and measurements of DA and metabolites were performed as previously described (Geldenhuys et al., 2009) . For static incubation, dissected and minced striatal tissue was equilibrated for 60 min, and effluent samples were collected three times at 20 min intervals. To examine extracellular levels of DA and its metabolites in vivo, microdialysis probes with 1 mm membrane length (CMA Microdialysis) were inserted in the ventral striatum. Probes were perfused with sterile artificial cerebrospinal fluid at a rate of 1.5 ml/min. Microdialysates were collected at 2 hr intervals after 2 hr of preperfusion. DA, DOPAC, and HVA were analyzed by reverse-phase high-performance liquid chromatography coupled with electrochemical detection. Detailed procedures are described in the Extended Experimental Procedures.
Electrophysiological Recording
A microdrive array (i.e., hyperdrive) composed of eight to nine tetrodes and one reference electrode was used for electrophysiological recording in the VTA of freely moving mice. Neuronal spiking data were amplified and digitized using a Digital Lynx data acquisition system (Neuralynx). Detailed procedures are described in the Extended Experimental Procedures.
Cell Culture
Cell culture materials were obtained from Invitrogen. CATH.a cells were maintained in RPMI1640 supplemented with 4 mM glutamine, 1 mM sodium pyruvate, 100 U/ml penicillin/streptomycin, and 10% fetal bovine serum. Transfection and luciferase-reporter assay are described in the Extended Experimental Procedures.
ChIP Assay
ChIP assays were performed using a commercial assay kit (Thermo Fisher Scientific) with modifications as described in the Extended Experimental Procedures.
Statistics
Group differences were evaluated using Student's t tests or one-way ANOVA followed by Newman-Keuls comparisons. Locomotion and neuronal firing rates were evaluated by repeated-measures ANOVA (RM-ANOVA) followed by Bonferroni tests. Significance was set at p < 0.05.
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